HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Montserrat Cortés Selected Research

Montserrat Cortés Research Topics

Disease

4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2024 - 08/2015
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2016 - 03/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2021
1Residual Neoplasm
02/2021
1Thrombosis (Thrombus)
03/2015
1Diarrhea
03/2015
1Breast Neoplasms (Breast Cancer)
11/2013
1Neoplasms (Cancer)
11/2013
1Pathologic Complete Response
11/2013
1Mycoses (Diseases, Fungus)
10/2005
1Neutropenia
10/2005
1Invasive Fungal Infections
10/2005
1Hematologic Neoplasms (Hematological Malignancy)
10/2005

Drug/Important Bio-Agent (IBA)

3Tyrosine Kinase InhibitorsIBA
01/2024 - 08/2015
3Imatinib Mesylate (Gleevec)FDA Link
10/2022 - 08/2015
3Inosine Triphosphate (ITP)IBA
09/2016 - 03/2015
3eltrombopagFDA Link
09/2016 - 03/2015
2NucleotidesIBA
10/2022 - 08/2015
1Circulating Tumor DNAIBA
02/2021
1Chimeric Antigen ReceptorsIBA
02/2021
1CD19 AntigensIBA
02/2021
1Thrombopoietin ReceptorsIBA
04/2015
1romiplostimFDA Link
04/2015
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
04/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2015
1Lapatinib (GW572016)FDA Link
11/2013
1Trastuzumab (Herceptin)FDA Link
11/2013
1human ERBB2 proteinIBA
11/2013
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2013
1liposomal amphotericin BFDA Link
10/2005

Therapy/Procedure

3Therapeutics
02/2021 - 10/2005
1Salvage Therapy
10/2005